![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Richard Furman, MD
ALL Specialist
Specialities: Acute Lymphocytic Leukemia
Spoken languages: English
-min_30b108db-ffda-4f68-a776-427bed864ef4.jpg?alt=media&token=7fae0fe4-f10f-4e19-92af-f98b9353e954)
Clinical Expertise
- Acute Lymphoblastic Leukemia
About
Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicine and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology. His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.
Location
Weill Cornell Medical Center: 425 E 61st St 8th floor, New York, NY 10065, USA
Get the latest thought leadership on your Acute Lymphocytic Leukemia delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2024 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811